Pfizer $PFE reported results today. You could say that the results beat expectations, but the revenue just missed expectations. Revenue was down from Q1 this year as sales of the Covid-19 vaccine fell 83% and revenue from the Paxlovide antiviral treatment fell 98%.
I've been buying $PFE shares recently as they are currently at a really low price.
Do you have shares of $PFE included in your portfolio?
A community member's personal view, not investment advice. Community Guidelines
Somehow I'm not attracted to this company, so I'm not including
I have PFE and will probably add more. It's at a pre-covid price, which I think indicates it's undervalued. 4.5% divi yield, which is great covered by free cash is great too.
I thought some of their medicine they put in didn't pass or am I wrong? On the other hand, they'll probably have a lot of other ones:)
We use essential cookies to run the website and optional analytics cookies to measure usage.
